CASTLEARK MANAGEMENT LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1106832 CHICAGO, IL

Position in LGND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,722,156

-$2,895,619 QoQ

Shares Held

48,696

-27.0% QoQ

Ownership

0.243%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CASTLEARK MANAGEMENT LLC holds $80,833,875 across 14 Biotechnology names. LGND ranks #2 (12.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	67,616	$15,465,807
2	LGND	Ligand Pharmaceuticals Inc This page	48,696	$9,722,156
3	JAZZ	Jazz Pharmaceuticals plc	48,740	$9,214,297
4	KRYS	Krystal Biotech, Inc.	31,630	$8,170,661
5	ARQT	Arcutis Biotherapeutics, Inc.	293,460	$6,913,917
6	PTCT	Ptc Therapeutics, Inc.	91,880	$6,259,784
7	BBIO	BridgeBio Pharma, Inc.	81,737	$6,069,789
8	RYTM	Rhythm Pharmaceuticals, Inc.	52,279	$4,546,704

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,722,156	48,696	-27.0%	Shares	Sole	2026-05-15
2025-12-31	$12,617,775	66,736	+3.2%	Shares	Sole	2026-02-13
2025-09-30	$11,456,706	64,676	-2.7%	Shares	Sole	2025-11-17
2025-03-31	$6,987,919	66,463	+2.1%	Shares	Sole	2025-05-15
2024-12-31	$6,976,857	65,113	-4.1%	Shares	Sole	2025-02-18
2024-09-30	$6,798,413	67,923	+10.7%	Shares	Sole	2024-11-15
2024-06-30	$5,170,446	61,363	-0.9%	Shares	Sole	2024-08-14
2024-03-31	$4,525,840	61,913	-1.3%	Shares	Sole	2024-05-16
2023-12-31	$4,478,176	62,702	+60.0%	Shares	Sole	2024-02-15
2023-09-30	$2,347,785	39,182	-2.0%	Shares	Sole	2023-11-15
2023-06-30	$2,884,144	40,002	+65.9%	Shares	Sole	2023-08-16
2020-06-30	$1,682,633	24,115	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.